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T cells producing IFNγ play a pathogenic role in the development of inflammatory bowel
disease (IBD). To investigate the functions of CD1d-dependent invariant natural killer T
(iNKT) cells in experimental colitis induced in Yeti mice with dysregulated expression
of IFNγ, we generated iNKT cell-deficient Yeti/CD1d KO mice and compared colitis
among WT, CD1d KO, Yeti, and Yeti/CD1d KO mice following DSS treatment. We
found that deficiency of iNKT cells exacerbated colitis and disease pathogenesis was
mainly mediated by NK1.1+CD8+ T cells. Furthermore, the protective effects of iNKT
cells correlated with up-regulation of regulatory T cells. Taken together, our results have
demonstrated that CD1d-dependent iNKT cells and CD1d-independent NK1.1+CD8+ T
cells reciprocally regulate the development of intestinal inflammatory responses mediated
by IFNγ-dysregulation. These findings also identify NK1.1+CD8+ T cells as novel target
cells for the development of therapeutics for human IBD.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract
that is caused by dysregulated immune responses to host intestinal bacterial flora (1). Human
IBD can be divided into two major types, Crohn’s disease and ulcerative colitis (UC), which share
symptoms and treatment options but differ in their pathogenic features and expression profiles of
inflammatory mediators. Crohn’s disease is characterized by excessive T helper 1 (Th1) responses
and involves pathogenic lesions in any part of the gastrointestinal tract, whereas UC is characterized
by Th2-dominant conditions that result in lesions restricted to the colon and rectum (1). Moreover,
it has been reported that increased Th17 immune responses are also associated with the progression
of both Crohn’s disease and UC (2). In mice, IBD can be acutely induced by oral administration of
dextran sulfate sodium (DSS) and this colitis is characterized by elevated Th1 and Th17 cytokine
responses.
The development of colitis involves a variety of immune cells, including dendritic cells (DCs),
macrophages, monocytes, neutrophils, conventional αβ T cells, γδ T cells, natural killer (NK) cells,
natural killer T (NKT) cells, and innate lymphoid cells (ILC) that have been suggested to play either
protective or pathogenic roles (3–5). In particular, NKT cells, defined by expression of both NK
Lee et al. iNKT Cells Suppress DSS Colitis
cell markers (NK1.1 or DX5) and T cell markers (TCRβ or CD3)
and restriction by the MHC class I-related protein CD1d, display
several subsets with distinct cytokine profiles in gastrointestinal
lymphoid tissues, including Peyer’s patches (PP), lamina propria
(LP), and mesenteric lymph nodes (MLN) of the small and large
intestine (6). A role of CD1d-restricted type I NKT cells, also
called invariant NKT (iNKT) cells because of the expression
of an invariant TCR α chain (Vα14-Jα18 in mice and Vα24-
Jα18 in humans), in regulating the development of IBD is
well-established. For example, iNKT cells secreting IL13 play
pathogenic roles in the oxazolone-induced UC mouse model (7).
In contrast, adoptive transfer of IL9-producing iNKT cells (8)
or administration of iNKT cell ligands (9, 10) exerted protective
effects against DSS-induced colitis. In addition, roles for CD1d-
restricted type II and DX5+ NKT cells in preventing the
pathogenesis of IBD have been reported (11, 12). Additionally,
CD1d-independent NK1.1+ T cells have been identified in the
intestinal tissues of CD1d knockout (KO) mice (13, 14), but their
potential contribution to the pathogenesis of colitis has not been
explored.
Previously, Yeti mice were generated to monitor IFNγ-
expressing immune cells in vivo by targeting an IRES/yellow
fluorescent protein (YFP) reporter cassette downstream of the
endogenous ifng gene (15). However, these Yeti mice have
recently been reported to display autoinflammatory syndromes
mediated by chronically elevated levels of IFNγ due to enhanced
stability of IFNγ mRNA transcripts by using a polyA bovine
growth hormone sequence (16). Thus, Yeti mice can be used to
evaluate the role of IFNγ in chronic inflammatory conditions
such as IBD.
Here, we have investigated the role of iNKT cells in
colitis induced by DSS in Yeti mice with dysregulated IFNγ-
mediated intestinal inflammation. We found that CD1d-
deficiency exacerbated intestinal inflammation in these animals.
Moreover, we found that disease in these animals was
predominantly mediated by NK1.1+CD8+ T cells. Furthermore,
we found that disease suppression mediated by iNKT cells was
linked with the expansion of Foxp3+ regulatory T (Treg) cells.
MATERIALS AND METHODS
Mice
Wild-type (WT) C57BL/6 (B6) mice were purchased from
Jung Ang Lab Animal Inc. (Seoul, Korea). IFNγ/YFP (Yeti)
cytokine reporter mice were kindly provided by Dr. R. Locksley
(University of California at San Francisco, CA, USA). CD1d
KO mice were provided by Dr. A. Bendelac (University of
Chicago, IL, USA). Jα18 KO mice were provided by Dr.
M. Taniguchi (RIKEN, Yokohama, Japan). Yeti mice were
further crossed with either CD1d KO or Jα18 KO mice to
obtain Yeti/CD1d KO and Yeti/Jα18 KO mice, respectively.
All mice in this study were on a B6 genetic background,
were maintained at Sejong University, and were used for
experiments at 6–12 weeks of age. They were maintained on a
12-h light/12-h dark cycle in a temperature-controlled barrier
facility with free access to food and water. Mice were fed a γ-
irradiated sterile diet and provided with autoclaved tap water.
Age- and sex-matched mice were used for all experiments.
The animal experiments were approved by the Institutional
Animal Care and Use Committee at Sejong University (SJ-
20160704).
Induction of Colonic Inflammation
Mice were provided with 1.5% (w/v) DSS in the drinking water
for 5 days. Subsequently, groups of mice were given normal
control water for 5 days until sacrifice for experiments. To
evaluate the clinical symptoms of DSS-induced colitis, the mice
were monitored for a change in the percentage of body weight
(0, none; 1, 1–10%; 2, 11–20%; 3, >20%), stool consistency (0,
normal; 1, loose stool; 2, diarrhea), and bleeding (0, normal; 1,
hemoccult positive; 2, gross bleeding) on a daily basis during
colitis induction for 10 days. The body weight was expressed
as a percentage of weight change for each individual mouse
and was calculated relative to the starting body weight on day
0. These data were used to calculate a disease activity index
(DAI).
Cell Culture and Cell Enrichment by
Magnetically Activated Cell Sorting (MACS)
A single-cell suspension of splenocytes was prepared and
resuspended in RPMI complete medium consisting of RPMI
1640 (Gibco BRL, USA) medium supplemented with 10% FBS,
10mM HEPES, 2mM L-glutamine, 100 units/mL penicillin-
streptomycin, and 5mM 2-mercaptoethanol. Naive CD4+ T cells
from Jα18 KO B6 mice were enriched with the CD4+CD62L+
T cell isolation kit II (Miltenyi Biotech, Bergisch Gladbach,
Germany), following the manufacturer’s instructions. The naive
CD4+ T cells were >94% pure among all MACS-purified
populations. iNKT cells were enriched using NK1.1+ iNKT cell
isolation kit (Miltenyi Biotech) following the manufacturer’s
instructions. The NKT cell population was >89% pure among
all MACS-purified populations. CD8+ T cells that include
NK1.1+CD8+ T cells but lack CD1d-dependent NKT cells
were enriched from MLN cells isolated from Yeti/CD1d KO
mice by negative selection of CD11c+ cells using anti-CD11c
MACS and LD column, followed by positive selection with the
CD8+ T cell MACS system. NK1.1−CD8+ T cells were enriched
from MLN cells isolated from Yeti/CD1d KO mice by first
removing NK1.1+ cells and CD11c+ cells using anti-CD11c
MACS and anti-PE MACS after staining with PE-conjugated
anti-NK1.1 (clone PK-136) mAb and LD column, followed by
positive selection with the CD8+ T cell MACS system. Cell
populations included >95% CD8+ cells among all MACS-
purified populations. IL15-cultured NK1.1+CD8+ T cells from
CD1d KO MLN were separated using Lympholyte-M (Cedar
Lane Laboratories Ltd., Hornby, Ontario, Canada) by density
gradient centrifugation and further positively selected for the
NK1.1+ population using anti-PE MACS after staining with PE-
conjugated anti-NK1.1 (clone PK-136) mAb. The NK1.1+CD8+
T cell population was >91% pure among all MACS-purified
populations.
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In vitro CD4+ and CD8+ T Cell
Differentiation
Recombinant murine IL15 and human TGFβ were purchased
from R&D systems (Minneapolis, MN, USA) and recombinant
murine IL2 was purchased from Peprotech (Hamburg,
Germany). For in vitro stimulation, rIL15, rTGFβ, and rIL2
were used at a concentration of 10 ng/ml. Lipopolysaccharide
(LPS) derived from E. coli (serotype 0111:B4) was purchased
from Sigma-Aldrich (St. Louis, MO, USA). For CD4+ T cell
differentiation, anti-IFNγ mAbs (5µg/ml; clone XMG1.2, BD
Biosciences) were added at the concentrations indicated in figure
legends. Isolated naive CD4+CD62L+ T cells (1× 105 cells/well)
were cultured with 96-well plate-bound anti-CD3ε (10µg/ml) +
anti-CD28 (1µg/ml) mAbs in the presence of rTGFβ (10 ng/ml)
and rIL2 (10 ng/ml) for 5 days. For CD8+ T cell differentiation,
MLN NK1.1+CD8+ T cell-depleted CD8+ T cells (5 × 105
cells/ml) isolated from either CD1d KO or Yeti/CD1d KO mice
were cultured with rIL15 (10 ng/ml) in 24-well plates for 5 or 10
days.
Flow Cytometry
The following monoclonal antibodies (mAbs) were obtained
from BD Biosciences (San Jose, USA): phycoerythrin (PE)-, or
allophycocyanin (APC)-conjugated anti-NK1.1 (clone PK-136);
PE-Cy7-, or APC-conjugated anti-CD4 (clone RM4-5); PE-Cy7-
conjugated anti-TCRβ (clone H57-597); PE-Cy7-conjugated
anti-CD8α (clone 53-6.7); PE-Cy7-, or APC-conjugated anti-
CD3ε (clone 145-2C11); PE-Cy7-conjugated anti-CD11b
(clone M1/70); APC-conjugated anti-CD25 (clone PC61);
APC-conjugated anti-CD44 (clone IM7); APC-conjugated
anti-CD314 (NKG2D) (clone CX5); PE-conjugated anti-IL12p40
(clone C15.6); PE-conjugated anti-TNFα (clone XP6-XT22); and
PE-conjugated anti-IgG1 (κ isotype control).
The following mAbs from eBioscience were used: PE-
conjugated anti-Ly49A (clone A1); PE-conjugated anti-FasL
(clone MFL3); APC-conjugated anti-F4/80 (clone BM8); PE-
conjugated anti-Perforin (clone eBioOMAK-D); PE-conjugated
anti-IFNγ (clone XMG1.2); PE-conjugated anti-IL17A (clone
eBio17B7); PE-conjugated anti-Eomes (clone Dan11mag); and
PE-conjugated anti-Foxp3 (clone NRRF-30). The following mAb
from R&D Systems was used: Biotin-conjugated anti-IL15. Flow
cytometric data were acquired with a FACSCalibur system
(Becton Dickinson, USA) and analyzed with FlowJo software
(Tree Star, USA).
For surface antibody staining, cells were harvested and
washed twice with cold 0.5% BSA-containing PBS (FACS buffer).
For blocking non-specific binding to Fc receptors, the cells
were incubated with anti-CD16/CD32 mAbs on ice for 10min
and subsequently stained with fluorescence-labeled mAbs. Flow
cytometric data were acquired using a FACSCalibur flow
cytometer (Becton Dickson, San Jose, CA, USA) and analyzed
using FlowJo software (Tree Star Inc., Ashland, OR, USA).
Intracellular Cytokine Staining
For intracellular staining, splenocytes were incubated with
brefeldin A, an intracellular protein transport inhibitor
(10µg/ml), in RPMI medium for 2 h at 37◦C. The cells were
stained for cell surface markers, fixed with 1% paraformaldehyde,
washed once with cold FACS buffer, and permeabilized with
0.5% saponin. The permeabilized cells were then stained for an
additional 30min at room temperature with the indicated mAbs
(PE-conjugated anti-IL12p40, anti-IFNγ, anti-IL17A, and anti-
perforin; PE-conjugated isotype control rat IgG mAbs). Fixation
and permeabilization were performed using a Foxp3 staining
kit (eBioscience) with the indicated mAbs (FITC-conjugated
anti-Foxp3; PE-conjugated anti-Foxp3; FITC- or PE-conjugated
isotype control rat IgG mAbs). More than 5,000 cells per sample
were acquired using a FACSCalibur, and the data were analyzed
using the FlowJo software package (Tree Star, Ashland, OR,
USA).
Isolation of Colon MLN, IEL, and LP
Leukocytes
The MLN were aseptically removed, and single-cell suspensions
of the MLN were obtained by homogenization and passing
through a 70µm nylon cell strainer. The large intestines were
removed and flushed with 20ml of cold CMF solution (Ca2+-
Mg2+-free PBS containing 10mM HEPES, 25mM sodium
bicarbonate, and 2% FBS). After exclusion of PP, fat, and mucus,
the large intestine was cut longitudinally into 5mmpieces and the
pieces of tissue were washed twice with CMF solution. The tissues
were transferred into 15ml pre-warmed EDTA/DTT/FBS/CMF
solution (CMF containing 1mM EDTA, 1mM DTT, 10% FBS,
and 100 units/mL penicillin-streptomycin) and stirred in 37◦C
shaking/orbital incubator for 30min to obtain intraepithelial
lymphocytes (IEL). The cell-containing suspension was passed
through a 70µm nylon cell strainer (BD Falcon), and put on
ice. IELs were purified from the interface of a 40/70% Percoll
(GE Healthcare) gradient after centrifugation for 20min at
2,400 rpm at RT. To isolate the lamina propria lymphocytes
(LPLs), the remaining intestinal tissues were cut into small pieces
using a scalpel and transferred to conical tubes. Tissues were
resuspended in 20ml of complete RPMI containing 2.5 mg/ml
collagenase type IV (Sigma, St. Louis, MO, USA) and 1 mg/ml
DNase I (Promega, Madison, USA) and shaken at 200 rpm
for 40min at 37◦C. At the end of the incubation, the digested
tissues were dissociated into single-cell suspensions using gentle
MACS Dissociator (Miltenyi, Germany) in combination with
C Tubes. The cell-containing suspension was passed through
a 70µm nylon cell strainer (BD Falcon), and put on ice.
LPLs were purified from the interface of a 40/70% Percoll (GE
Healthcare) gradient after centrifugation for 20min at 2,400 rpm
at RT.
Histology
Distal colonic sections were fixed in 4% paraformaldehyde,
embedded in paraffin, and cut into 6µm sections using a
microtome (RM 2235, Leica, Germany). The sections were then
stained with H&E for the analysis of histological changes. The
histological score of each individual mouse was measured as
follows: epithelial damage (E), 0 = none; 1 = minimal loss of
goblet cells; 2 = extensive loss of goblet cells; 3 = minimal loss
of crypts and extensive loss of goblet cells; 4 = extensive loss of
crypts; and infiltration (I), 0= no infiltrate; 1= infiltrate around
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the crypt basis; 2 = infiltrate reaching the muscularis mucosa;
3 = extensive infiltration reaching the muscularis mucosa and
thickening of the mucosa with abundant edema; 4 = infiltration
of the submucosa. The total histological score was calculated as
E+I.
Cytotoxicity Assay
The flow cytometric CFSE/7-AAD cytotoxicity assay
was performed as previously described (17) with minor
modifications. NK1.1−CD8+ T cells and NK1.1+CD8+ T cells
were isolated as described above and suspended in complete
RPMI medium. B16 melanoma cells (3 × 106) were labeled
with 500 nM CFSE in Hanks’ Balanced Salt Solution for 10min
at 37◦C in a volume of 2ml. The cells were washed twice in
RPMI medium and used immediately. The CFSE-labeled target
cells (20,000 cells) were incubated with either NK1.1−CD8+
T cells or NK1.1+CD8+ T cells at different effector (E): target
(T) ratios (0:1, 3:1, 9:1, and 27:1). After 10 h of incubation, cells
were stained with 0.25µg/ml of 7-AAD and were incubated
for 10min at 37◦C in a CO2 incubator. Cells were washed
twice with 1× PBS containing 1% FBS (FACS buffer) and
resuspended in FACS buffer. Cytotoxicity was assessed by flow
cytometry.
Statistical Analysis
Statistical significance was determined using Excel (Microsoft,
USA). Student’s t-test was performed for the comparison of
two groups. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 were
considered to be significant in the Student’s t-test. Two-way
ANOVA analysis was carried out using the VassarStats (http://
vassarstats.net/anova2u.html). #P < 0.05, ##P < 0.01, and ###P
< 0.001 were considered to be significant in the two-way
ANOVA.
RESULTS
Yeti Mice Have Increased Numbers of
CD1d-Independent NK1.1+CD8+ T Cells
Since it has been reported that IFNγ KOmice are protected from
DSS-induced colitis (18), we examined whether dysregulated
IFNγ expression in heterozygous Yeti mice, in which abnormal
IFNγ secretion occurs due to modification of the 3
′
-untranslated
region (UTR) of the IFNγ gene (16), influences colitis severity.
We confirmed that heterozygous Yeti mice display splenomegaly
and elevated levels of IL12-producing DCs and Th1 cells
compared with WT mice (Figures 1A,B).
While studying NKT cells in Yeti mice, we noticed that
the proportion and absolute number of NK1.1+CD8+ T cells
among total splenocytes were increased five- to eight-fold in Yeti
mice compared with WT mice. Moreover, a similar increase in
NK1.1+CD8+ T cells in Yeti mice was observed in NKT cell-
deficient Yeti/CD1d KO mice, consistent with the notion that
these cells are not CD1d-restricted (Figures 1C,D). Collectively,
these results suggest that the excessive inflammation in Yeti
mice might be associated with an increase in the numbers of
NK1.1+CD8+ T cells.
Yeti Mice Accelerate Intestinal
Inflammation in the Absence of iNKT Cells
Since iNKT cells can provide protective effects against DSS-
induced colitis (8, 9), we decided to examine whether these
cells play a role in regulating intestinal inflammation in Yeti
mice. To address this possibility, we generated iNKT cell-
deficient Yeti/CD1d KO mice by crossing Yeti mice with CD1d
KO mice. We compared the colitic symptoms among WT,
CD1d KO, Yeti, and Yeti/CD1d KO mice following 1.5% DSS
treatment. Yeti/CD1d KO mice showed more severe weight loss,
diarrhea, and bleeding in feces, resulting in a steep increase in
the DAI score, compared with the different groups of control
mice (Figure 2A). Furthermore, the colon length in DSS-treated
Yeti/CD1d KO mice was remarkably shortened (Figure 2B) and
displayed increased signs of colonic inflammation, with loss
of epithelial crypts, edema, and infiltration of inflammatory
cells (Figure 2C). In addition, we found that Th1 and Th17
differentiation of CD4+ T cells in the spleen, MLN, and
LP from Yeti and Yeti/CD1d KO mice was significantly
increased as compared with WT and CD1d KO mice after
DSS administration. The frequencies of Th1 and Th17 cells
in Yeti/CD1d KO mice were two- to three-fold greater in the
MLN and LP, but not in the spleen, than those from Yeti mice,
indicating that the protective role of iNKT cells in colitis was
largely restricted to the MLN and LP (Figure 2D). On the other
hand, colitis in CD1d KO mice was only slightly increased
compared with WT mice, suggesting that lack of iNKT cells by
itself is not sufficient to induce exacerbated colitis.
Since CD1d KO mice lack iNKT (Type I) cells as well
as type II NKT cells, we generated Yeti/Jα18 KO mice by
crossing Yeti mice with Jα18 KO mice that selectively lack
iNKT cells. Upon administration of DSS, Yeti/Jα18 KO mice
showed significantly higher disease activity than the control mice
(Supplementary Figures 1A,B). Taken together, these results
indicate that CD1d-dependent iNKT cells play a major role in
controlling DSS-induced colitis in Yeti mice.
IL10 KO and IL2 KO mice spontaneously develop colitis
when raised under conventional conditions by dysregulated
immune responses against commensal bacteria (19, 20). To
investigate whether WT, CD1d KO, Yeti, and Yeti/CD1d KO
mice develop intestinal inflammation spontaneously when raised
under conventional conditions, we measured body weights once
a week for 12 weeks. We observed that Yeti/CD1d KO mice
gained body weight more slowly compared with the other groups
of mice (Figure 2E). Furthermore, unexpectedly, the incidence of
rectal prolapse was significantly increased in Yeti/CD1d KOmice
(Figure 2F). This was confirmed by histological examination of
H&E-stained colon sections (Figure 2G). Taken together, these
results suggest that colitic pathogenesis in Yeti/CD1d KOmice is
mainly attributed to both deficiency of iNKT cells and increase of
NK1.1+CD8+ T cells.
NK1.1+CD8+ T Cells With Effector/Memory
Phenotypes Strongly Correlate With Severe
Intestinal Inflammation in Yeti Mice
Since our results showed that the numbers of NK1.1+CD8+ T
cells were increased in Yeti mice at steady state, we investigated
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FIGURE 1 | Altered NKT cell subsets in Yeti mice. (A) Left, a representative picture of the spleens from 8-week-old WT B6 and heterozygous Yeti B6 mice. Middle and
Right, Spleen weight and splenocyte number in Yeti B6 and Yeti Balb/c mice, as compared with WT B6 and Balb/c mice. (B) Intracellular IL12 production by isolated
DCs (CD11c+) from WT B6 and Yeti B6 mice was assessed by flow cytometry. Intracellular IFNγ production was assessed in splenic CD4+ T cells from WT B6 or Yeti
B6 mice by flow cytometry. (C) The percentage of NK1.1+TCRβ+ cells among splenocytes and the percentage of either CD4+ or CD8α+ populations among
NK1.1+ T cells from 8-week-old WT and Yeti mice are plotted. The proportion and absolute cell numbers of CD4+, CD8+, and DN NK1.1+ T cells were assessed in
WT and Yeti mice at the age of 8 weeks. (D) The percentage of NK1.1+ populations among CD8α+ T cells from 8-week-old WT, Yeti, CD1d KO, and Yeti/CD1d KO
mice are plotted. The mean values ± SD (n = 4 per group in the experiment; Student’s t-test; **P < 0.01, ***P < 0.001) are shown. Two-way ANOVA (Yeti × iNKT)
showed an interaction between these two factors (ns, not significant).
whether NK1.1+CD8+ T cells are closely related with the
intestinal inflammatory processes in Yeti mice. In DSS-induced
colitis, the number of NK1.1+CD8+ T cells in the spleen
and MLN from Yeti mice was expanded approximately 6-fold
compared with WT mice, and the number of NK1.1+CD8+
T cells from Yeti/CD1d KO mice was increased eight-fold
compared with CD1d KO mice (Figure 3A). Moreover, when
colitis was spontaneously induced, the number of NK1.1+CD8+
T cells in the spleen and MLN from Yeti/CD1d KO mice with
a prolapse were three- to four-fold higher compared to those
from Yeti/CD1d KO mice without prolapse (Figure 3B), which
strongly indicates that NK1.1+CD8+ T cells are pathogenic
effector cells. Moreover, there was a strong positive correlation
between NK1.1+CD8+ T cell number and the histological score
of colon tissue samples in both the spleen (R2 = 0.91) and MLN
(R2 = 0.94) (Figure 3C). Taken together, these findings suggest
that NK1.1+CD8+ T cells are pathogenic cells contributing to
severe and spontaneous colitis in Yeti/CD1d KO mice.
In previous reports, NK1.1-expressing CD8+ T cells were
shown to display significant cytotoxicity against tumor cells
and to possess a memory phenotype with a pro-inflammatory
cytokine production profile (21, 22). Thus, we examined the
expression of memory markers (CD44 and Eomes), NK cell
receptors (NKG2D and Ly49a), cytolytic molecules (FasL and
Perforin), and pro-inflammatory cytokines (IFNγ and TNFα) in
MLN-derived NK1.1+CD8+ T cells from Yeti/CD1d KO mice
during DSS-induced colitis. We found that NK1.1+CD8+ T
cells from DSS-treated mice, unlike unstimulated NK1.1−CD8+
Frontiers in Immunology | www.frontiersin.org 5 October 2018 | Volume 9 | Article 2168
Lee et al. iNKT Cells Suppress DSS Colitis
FIGURE 2 | Lack of iNKT cells accelerates intestinal inflammation in Yeti mice. Daily body weight changes, DAI score (A) and colon length (B) of WT, Yeti, CD1d KO,
and Yeti/CD1d KO mice were evaluated after 1.5% DSS treatment. Data are representative of three independent experiments with similar results. (C) On day 10, distal
colons from each group were sectioned and stained with H&E. (D) Intracellular IFNγ and IL17 production were assessed in splenic, MLN, and LP CD4+ T cells from
these mice by flow cytometry on day 10. The mean values ± SD (n=5 per group in the experiment; Student’s t-test; *P < 0.05, **P < 0.01, ***P < 0.001) are shown.
Two-way ANOVA (Yeti × iNKT and genotype × tissue) showed an interaction between these two factors (#P < 0.05, ##P < 0.01, ###P < 0.001). Daily body weight
changes (E) and prolapse rate (F) of WT, Yeti, CD1d KO, and Yeti/CD1d KO mice housed for 12 weeks under conventional conditions. (n = 7 for WT, Yeti, and CD1d
KO mice; n = 10 for Yeti/CD1d KO mice; Student’s t-test; *P < 0.05, **P < 0.01). (G) Left, distal colons from these mice were sectioned and stained with H&E at
week 12. Right, histologic damages were scored from H&E-stained sections at week 12. (n = 5 for WT, Yeti, and CD1d KO mice; n = 5 for Yeti/CD1d KO mice (no
signs); n = 3 for Yeti/CD1d KO (prolapse); Student’s t-test; **P < 0.01, ***P < 0.001).
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FIGURE 3 | The development of colitis in Yeti/CD1d KO mice is associated with increased numbers of NK1.1+CD8+ T cells. The spleen and MLN were obtained
from 1.5% DSS-treated WT, Yeti, CD1d KO, and Yeti/CD1d KO mice at day 10. (A) The absolute numbers of NK1.1+CD8+ T cells in the indicated tissues from these
(Continued)
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FIGURE 3 | mice were assessed by flow cytometry at day 10. The mean values ± SD (n = 5 per group in the experiment; Student’s t-test; **P < 0.01, ***P < 0.001)
are shown. Two-way ANOVA (Yeti × iNKT) showed an interaction between these two factors (#P < 0.05, ##P < 0.01). (B,C) The spleen and MLN were isolated from
WT, Yeti, CD1d KO, and Yeti/CD1d KO mice at 12 weeks after initiation of conventional housing conditions. (B) Upper left, the percentage of NK1.1+CD3+ cells
among splenocytes and MLN cells of these mice was determined at week 12. Lower left, the frequency of the CD8α+ population among NK1.1+CD3+ cells from the
spleen and MLN of these mice was determined at week 12. Right, the absolute numbers of NK1.1+CD8+ T cells in the spleen and MLN were assessed by flow
cytometry at week 12. (n = 5 for WT, Yeti, and CD1d KO mice; n = 5 for Yeti/CD1d KO mice (no signs); n = 3 for Yeti/CD1d KO (prolapse); Student’s t-test; *P < 0.05,
**P < 0.01, ***P < 0.001). (C) Scatter graphs and linear regression analysis of the relationship between the frequency of NK1.1+CD8+ T cells among total
splenocytes or MLN cells and histological score of colon tissue sections in Yeti/CD1d KO mice. The Pearson’s correlation coefficient (R2) for each plot is indicated. (n
= 5 for Yeti/CD1d KO mice (no signs); n = 3 for Yeti/CD1d KO (prolapse)). (D) The expression of CD44, Eomes, NKG2D, Ly49a, FasL, perforin, IFNγ, and TNFα
among NK1.1−CD8+ T cells, NK1.1+CD8+ T cells, and NK cells of the MLN from 1.5% DSS-treated Yeti/CD1d KO mice was evaluated by flow cytometry on day
10. The mean values ± SD (n = 4 in A–C; n = 5 in D; per group in the experiment; Student’s t-test; *P < 0.05, **P < 0.01, ***P < 0.001) are shown.
T cells, exhibit an effector CD8+ T cell phenotype with NK
cell-like functions, suggesting that NK1.1+CD8+ T cells are
pathogenic cells causing severe intestinal inflammation in Yeti
mice (Figure 3D).
The NK1.1+CD8+ T Cell Population Is
Primarily Responsible for Induction of DSS
Colitis in Yeti Mice
It has been reported that colitogenic CD8+ T cells have an
effector phenotype with increased expression of IFNγ and
Granzyme B (23). Since the increased NK1.1+ population among
Yeti CD8+ T cells produced high levels of pro-inflammatory
cytokines and cytolytic molecules, we decided to examine
whether the pathogenic capacity of Yeti CD8+ T cells was
mediated by the NK1.1+ subpopulation. To test this possibility,
we adoptively transferred MLN total CD8+ T cells or MLN
NK1.1−CD8+ T cells from Yeti/CD1d KO into CD1d KO mice
and treated these animals with 1.5% DSS (Figure 4A). Mice
that received total CD8+ T cells showed progressive symptoms
of colitis compared with uninjected mice, whereas disease in
mice that received NK1.1−CD8+ T cells was very similar to
uninjected mice (Figures 4B,C). Moreover, mice that received
NK1.1−CD8+ T cells displayed a significant decrease in the
frequencies of Th1 and Th17 cells in the MLN and LP compared
to mice that received total CD8+ T cells including NK1.1+CD8+
T cells (Figure 4D). Overall, these results provide strong evidence
that NK1.1+CD8+ T cells play a pivotal role in mediating the
pathogenesis of DSS-induced colitis in Yeti mice.
Lack of CD1d-Restricted iNKT Cells
Increases Susceptibility to Colitis Induced
by NK1.1+CD8+ T Cells
It has been reported that the common gamma chain (γc) cytokine
IL15 directly induces NK1.1 expression on sorted CD8+ T
cells (24). Consistent with this previous study, we found that
NK1.1−CD8+ T cells cultured with IL15 significantly expressed
higher levels of NK1.1 compared to cells cultured without
cytokines (Figure 5A). Furthermore, we found that IFNγ-YFP
reporter knockin increases NK1.1 expression on NK1.1−CD8+
T cells in response to IL15 stimulation (Figure 5B). We
also found that IL15-induced NK1.1+CD8+ T cells expressed
high levels of cytolytic molecules such as NKG2D, perforin,
and FasL, indicating that IL15-induced NK1.1+CD8+ T cells
display similar phenotypic profiles as Yeti NK1.1+CD8+ T cells
(Figure 5C). Furthermore, we demonstrated that IL15-induced
NK1.1+CD8+ T cells, unlike unstimulated NK1.1−CD8+ T cells,
are effector cells with cytotoxic function against B16 melanoma
cells (Figure 5D).
Previously, iNKT cells and NK1.1+CD8+ T cells have been
implicated in the development of colitis (8, 14), but their
interactions remain largely unknown. Importantly, adoptive
transfer of IL15-induced NK1.1+CD8+ T cells resulted in
a significant increase in DSS-induced weight loss and DAI
score in the absence of iNKT cells, whereas DSS-induced
colitis exacerbated by injection of IL15-induced NK1.1+CD8+
T cells was dramatically halted by the presence of iNKT cells
(Figure 5E). Upon DSS-induced colitis, when compared with
CD1d KO mice, WT mice that received NK1.1+CD8+ T cells
showed significantly decreased frequency of Th1 and Th17 cells
in the LP (Figure 5F). Collectively, these data demonstrate that
NK1.1+CD8+ T cells are pathogenic in DSS colitis in the absence
of iNKT cells.
NK1.1+CD8+ T Cells Mediate Inhibitory
Effects on Treg Cell Differentiation in
Intestinal Inflammation
The loss of colonic Treg cells induces excessive infiltration
of inflammatory immune cells that results in colitis (25). A
previous study demonstrated that IFNγ inhibits the generation
of inducible Treg (iTreg) (26). In addition, activated NKT cells
modulate Treg function in an IL2-dependent manner (27). Thus,
we examined whether the lack of iNKT cells could affect the
distribution of Treg cells in DSS-treated Yeti mice. Intriguingly,
DSS-treated Yeti/CD1d KO mice contained fewer Treg cells
in the MLN and LP, but not in the spleen when compared
with WT, Yeti, and CD1d KO mice (Figures 6A,B). Taken
together, these data suggest that the combined loss of iNKT
cells and dysregulated IFNγ production can induce a decrease
in protective Foxp3+CD25+CD4+ T cells during DSS-induced
colitis. As expected, IL15-induced NK1.1+CD8+ T cells, unlike
unstimulated NK1.1−CD8+ T cells, produced high levels of
IFNγ (Figure 6C). Moreover, consistent with a previous study
(28), our results showed that NK1.1+CD8+ T cell-derived
IFNγ acts as a potent inhibitor of Treg cell differentiation
(Figure 6D). Upon DSS-induced colitis, when compared with
CD1d KO mice, WT mice that received NK1.1+CD8+ T cells
displayed significantly increased frequency of Treg cells in the
LP (Figure 6E). Collectively, these data strongly suggest that
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FIGURE 4 | The NK1.1+ population among CD8+ T cells is mainly responsible for colitis in Yeti mice. (A) The percentage of NK1.1+CD8+ T cells among total CD8+
T cells and NK1.1+ cell-depleted CD8+ T cells from the MLN of Yeti/CD1d KO mice was determined. (B–D) Either total CD8+ T cells (2 × 106) or NK1.1−CD8+ T
cells (2 × 106) from Yeti/CD1d KO mice were i.v. transferred to CD1d KO mice. Daily body weight changes, DAI score (B), and colon length (C) of each group were
evaluated after 1.5% DSS treatment. (D) Intracellular IFNγ and IL17 production and the frequencies of Foxp3+CD25+ cells were assessed in the MLN and LP CD4+
T cells from these mice by flow cytometry on day 10. The mean values ± SD (n = 5 per group in the experiment; Student’s t-test; *P < 0.05, **P < 0.01) are shown.
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FIGURE 5 | CD1d-restricted iNKT cells exhibit inhibitory effects on the pathogenesis of NK1.1+CD8+ T cell-mediated colitis. (A) Purified NK1.1+ cell-depleted CD8+
T cells from the MLN of CD1d KO mice were cultured with rIL15 for 5 or 10 days. The percentage of the NK1.1+ population among all CD8+ T cells was evaluated by
flow cytometry at the indicated time points. (B) Purified NK1.1−CD8+ T cells from the MLN of CD1d KO and Yeti/CD1d KO mice were cultured with rIL15 for 5 or 10
days. The percentage of the NK1.1+ population among total CD8+ T cells was evaluated by flow cytometry at the indicated time points. (C) The expression of
NKG2D, perforin, and FasL among unstimulated NK1.1−CD8+ T cells or IL15-stimulated NK1.1+CD8+ T cells were assessed by flow cytometry on day 10 after
cytokine stimulation. (D) Cytotoxicity of either unstimulated NK1.1−CD8+ T cells or IL15-stimulated NK1.1+CD8+ T cells from the CD1d KO MLN was evaluated
using 7-AAD/CFSE assay. (E,F) Either NK1.1−CD8+ T cells (1 × 106) or IL15-stimulated NK1.1+CD8+ T cells (1 × 106) from the CD1d KO MLN were i.v. transferred
to CD1d KO mice. (E) Daily body weight changes and DAI score of each group were evaluated 10 days after 1.5% DSS treatment. (F) Intracellular IFNγ and IL17
production in LP CD4+ T cells from these mice were determined by flow cytometry on day 10. The mean values ± SD (n = 3 in D; n = 4 in A–C; n = 5 in E and F; per
group in the experiment; Student’s t-test; *P < 0.05, **P < 0.01, ***P < 0.001) are shown. Two-way ANOVA (genotype × treatment) showed an interaction between
these two factors (#P < 0.05).
Frontiers in Immunology | www.frontiersin.org 10 October 2018 | Volume 9 | Article 2168
Lee et al. iNKT Cells Suppress DSS Colitis
FIGURE 6 | iNKT cells prevent the reduction in the Treg population induced by
NK1.1+CD8+ T cells. (A,B) The spleen, MLN, and LP were obtained from WT,
Yeti, CD1d KO, and Yeti/CD1d KO mice at 10 days after 1.5% DSS treatment.
The percentage of Foxp3+CD25+ cells among CD4+ T cells from the spleen,
MLN, and LP of each group was evaluated by flow cytometry on day 10. Data
are representative of three independent experiments with similar results. The
mean values ± SD (n = 5 per group in the experiment; Student’s t-test; *P <
0.05, **P < 0.01) are shown. Two-way ANOVA (Yeti × iNKT) showed an
interaction between these two factors (###P < 0.001). (C) The expression of
IFNγ among unstimulated NK1.1−CD8+ T cells or IL15-stimulated
NK1.1+CD8+ T cells were assessed by flow cytometry on day 10
(Continued)
FIGURE 6 | after cytokine stimulation. (D) Naive CD4+CD62L+ T cells were
co-cultured in Treg-polarizing conditions for 5 days with either unstimulated
NK1.1−CD8+ T cells (1 × 104 cells) or IL15-stimulated NK1.1+CD8+ T cells
(1 × 104 cells) from the CD1d KO MLN. Neutralizing mAb specific to IFNγ was
added during the culture. The frequency of Foxp3+CD25+ cells among CD4+
T cells was evaluated by flow cytometry on day 5. Two-way ANOVA (treatment
× cell type) showed an interaction between these two factors (###P < 0.001).
(E) Either NK1.1−CD8+ T cells (1 × 106) or IL15-stimulated NK1.1+CD8+ T
cells (1 × 106) from the CD1d KO MLN were i.v. transferred to CD1d KO mice.
The frequencies of Foxp3+CD25+ cells in LP CD4+ T cells from these mice
were determined by flow cytometry on day 10. The mean values ± SD (n = 4
in C and D; n = 5 in E; per group in the experiment; Student’s t-test; *P <
0.05, **P < 0.01, ***P < 0.001) are shown. Two-way ANOVA (genotype ×
treatment) showed an interaction between these two factors (#P < 0.05).
NK1.1+CD8+ T cells become pathogenic by suppressing Treg
differentiation whereas iNKT cells can control the effects of
NK1.1+CD8+ T cells on Treg cells during the development of
colitis.
DISCUSSION
We have demonstrated here that the severity of low dose DSS
(1.5%)-induced colitis is exacerbated in heterozygous Yeti mice
on an NKT cell-deficient background, indicating that iNKT
cells are essential for maintaining intestinal homeostasis in the
context of IFNγ-mediated inflammation. We further showed
that iNKT cells and Treg cells contribute to colitis protection,
whereas expansion of CD1d-independent NK1.1+CD8+ T cells
contributes to colitis pathogenesis.
Previously, Lee et al. suggested that an IL4-dominant
environment in the MLN induced by oral administration of
α-GalCer suppresses Th1-driven Crohn’s disease but promotes
Th2-driven ulcerative colitis (29). Based on these previous
findings and our results reported here, the MLN might be a
critical site for iNKT2 cell-mediated protection against DSS-
induced colitis in Yeti mice. In addition to protein antigens
that can activate conventional T cells, commensal bacteria
contain glycolipid Ags, which are capable of activating iNKT
cells through TCR ligation by Ag/CD1d complexes, but not
TLR triggering (30). Sphingomonas/Sphingobium species, which
contain glycolipid Ags, activate intestinal iNKT cells to produce
cytokines in a CD1d-dependent manner (30), whereas intestinal
microbe Bacteroides fragilis-derived glycolipid Ags inhibit iNKT
cell activation through competitive binding with CD1d, resulting
in protection against oxazolone-induced colitis (31). Thus, it is
tempting to speculate that reduced survival of Treg cells in a Th1
cytokine-dominant environment triggered in Yeti mice might be
inhibited by iNKT cells in response to glycolipid Ags derived
from intestinal commensal bacteria.
Next, we investigated the cell types that contribute to disease
pathogenesis in DSS-induced colitis under IFNγ dysregulated
conditions. Since prior reports that CD1d-independent
NK1.1+CD8+ T cells producing high levels of IFNγ and TNFα
are involved in diverse immune responses such as tumor immune
surveillance, allogeneic hematopoietic cell transplantation, and
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viral infection (21, 22, 32, 33), we considered the possibility
that such cells might be involved. We found an expansion
of NK1.1+CD8+ T cells during the development of DSS
and spontaneous colitis in Yeti mice, and adoptive transfer
experiments provided direct evidence for a pathogenic role of
these cells in colitis.
Based on the previous report that IFNγ and IL12 do
not directly up-regulate NK1.1 expression on the surface of
CD8+ T cells (24), an increase in NK1.1-expressing CD8+
T cells might be attributed to enhanced IL15 secretion by
mononuclear phagocytes (34–36), which is consistent with our
observations that IL15 production in both DCs andmacrophages
from Yeti mice was significantly increased in both the spleen
and MLN compared to WT mice, indicating that DCs and
macrophages might be critical sources of IL15 to increase
NK1.1+CD8+ T cells in Yeti mice (Supplementary Figure 2).
In muscle damage mediated by idiopathic inflammatory
myopathies, myoblast-derived IL15 induced the differentiation
of naive CD8+ T cells into highly activated and cytotoxic
NKG2DhighCD8+ T cells, which promoted myoblast damage
through NKG2D-dependent lysis induced by MHC class I
chain-related molecules (MICA and MICB) (37). Moreover,
in celiac disease, NKG2DhighCD8+ T cells induced by IL15
displayed cytotoxicity against intestinal epithelial cells expressing
high MIC levels in a TCR-independent and NKG2D-mediated
cytolysis pathway (38). Recently, it has been reported that in
acute hepatitis A patients, NKG2DhighCD8+ T cells induced
by IL15 promote damage of liver tissue expressing NKG2D
ligands such as MICA and MICB (39). Because stress induces
increased expression of MICA and MICB on human intestinal
epithelial cell lines (40), enhanced expression of murine NKG2D
ligands on intestinal epithelial cells of DSS-treated Yeti/CD1d
KO mice might trigger NK1.1+CD8+ T cell activation, which
in turn might exacerbate DSS-induced colitis. Moreover, Crohn’s
disease patients exhibit markedly increased expression of IL15
and IFNγ in the inflamed colon compared with healthy
people (41), indicating that NK1.1+CD8+ T cells involved in
intestinal inflammation in Yeti mice might be physiologically
relevant to the development of Crohn’s disease. It will be
of interest to further investigate what types of cells might
represent the human counterpart for murine NK1.1+CD8+ T
cells.
It has been reported that repression of IFNγ mRNA
decay leads to accumulation of self-reactive CD8+ T cells,
causing pancreas-specific damage (42). In addition, a recent
study showed that IFNγ production by CD4+ T cells from
homozygous Yeti mice is regulated by lactate dehydrogenase
A (LDHA) via a 3
′
UTR-independent mechanism, whereas
IFNγ production by NK cells was not affected by these
pathways (43). Consistent with the previous report that IFNγ
mRNA transcripts are maintained constitutively in NK receptor-
expressing innate immune cells such as NK cells and NKT cells
(44), we demonstrated that NK1.1+CD8+ T cells expressing
NK receptors constitutively produced large amounts of IFNγ.
Thus, our results suggest that NK1.1+CD8+ T cells might be
one of the main cellular sources of increased IFNγ in Yeti
mice, in which the stability of IFNγ mRNA transcripts is
enhanced.
A previous report revealed that IL15-induced NK1.1+CD8+
T cells display downregulated levels of TGFβ receptor, implying
that NK1.1+CD8+ T cells are inherently resistant to immune
suppression mediated by Treg-derived TGFβ (45). In addition,
our data showed that NK1.1+CD8+ T cells could strongly
attenuate Treg development via IFNγ signaling. These findings
suggest that IFNγ-producing NK1.1+CD8+ T cells cannot
respond to Treg cells and instead might inhibit Treg functions
in the intestine.
In conclusion, the overall severity of DSS-induced colitis is
determined by the extent of imbalance between protective and
pathogenic cells and factors. Since our results clearly showed
that iNKT cells are required for controlling NK1.1+CD8+ T cell-
mediated pathogenesis during DSS-induced colitis, glycolipid
antigens might be employed for designing more effective and
safer therapeutics for IBD. Since iNKT cells are known to have
subsets (iNKT1, iNKT2, and iNKT17), in future studies, it will be
of interest to determine which subsets of iNKT cells contribute
to the protective effect against NK1.1+CD8+ T cell-mediated
intestinal inflammation. It will also be important to confirm
such immunoregulatory roles of iNKT cells by employing more
specific iNKT cell-deficient mouse model, such as the strain
recently generated by CRISPR/Cas9 technology (46).
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